Definium Therapeutics, Inc. - Common Shares (NQ:DFTX)
Price and Volume
Detailed Quote| Volume | 1,278,438 |
| Open | 31.23 |
| Bid (Size) | 30.50 (100) |
| Ask (Size) | 33.42 (100) |
| Prev. Close | 30.36 |
| Today's Range | 30.91 - 33.41 |
| 52wk Range | 14.62 - 49.70 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
33.1% below 52-week high
33.27
14.6252W Low
49.7052W High
1 Week
9.7% below 1-week high
30.171W Low
36.841W High
Definium Therapeutics, Inc. - Common Shares (DFTX) traded between $14.62 and $49.70 over the past 52 weeks and last traded at $33.27, 33.1% below its 52-week high. Over the past week it ranged between $30.17 and $36.84.
Past 12 Months
1W
+$0.80
1M
-$1.82
3M
-$12.87
6M
+$11.22
YTD
+$17.89
1Y
+$17.89
DFTX was +116.3% over the past year, +50.9% over six months, +116.3% year to date, +2.5% in the last week.
12 Months vs Market
DFTX
+116.3%
DIA
+9.2%
SPY
+9.7%
QQQ
+7.3%
IWM
+13.9%
Over the past 12 months DFTX returned +116.3% versus DIA (Dow) +9.2%, SPY (S&P 500) +9.7%, QQQ (Nasdaq 100) +7.3% and IWM (Russell 2000) +13.9%.
Volume & Liquidity
0.59× 3-mo avg
Today 1,278,438
3-mo avg 2.2M
1W
2.0M
1M
1.9M
3M
2.2M
6M
2.5M
YTD
2.2M
1Y
2.2M
DFTX most recently traded 1,278,438 shares against a 3-month average daily volume of 2.2M.
More News
Read More
Definium Therapeutics Announces New Employee Inducement Grants
October 26, 2026
Definium Therapeutics Announces New Employee Inducement Grants
October 13, 2026
Definium Therapeutics Announces New Employee Inducement Grants
September 28, 2026
Definium Therapeutics’ DT120 Hits Phase III Goals in Anxiety Study ↗
September 19, 2026
Definium Therapeutics Announces New Employee Inducement Grants
September 14, 2026
Definium Therapeutics Announces New Employee Inducement Grants
August 31, 2026
Definium Therapeutics Announces New Employee Inducement Grants
August 17, 2026
Wondering what's happening in today's pre-market session? ↗
August 12, 2026
Definium Therapeutics Q2 Earnings Call Highlights ↗
August 06, 2026
Definium Therapeutics Announces New Employee Inducement Grants
August 03, 2026
Frequently Asked Questions
Is Definium Therapeutics, Inc. - Common Shares publicly traded?
Yes, Definium Therapeutics, Inc. - Common Shares is publicly traded.
What exchange does Definium Therapeutics, Inc. - Common Shares trade on?
Definium Therapeutics, Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Definium Therapeutics, Inc. - Common Shares?
The ticker symbol for Definium Therapeutics, Inc. - Common Shares is DFTX on the Nasdaq Stock Market
What is the current price of Definium Therapeutics, Inc. - Common Shares?
The current price of Definium Therapeutics, Inc. - Common Shares is 33.27
When was Definium Therapeutics, Inc. - Common Shares last traded?
The last trade of Definium Therapeutics, Inc. - Common Shares was at 11/06/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.